Chromosomal instability in meningiomas

Journal of Neuropathology and Experimental Neurology

Volumn 64, Issue 4, 2005, Pages 312-322

  Van Tilborg, Angela A G ^a   Al Allak, Bushra ^a   Velthuizen, Sandra C J M ^a   De Vries, Annie ^a   Kros, Johan M ^a   Avezaat, Cees J J ^a   De Klein, Annelies ^a   Beverloo, H Berna ^a   Zwarthoff, Ellen C ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

Chromosomal instability; Meningioma; Mitotic defects; NF2

Indexed keywords

ADULT; AGED; ANAPHASE; ARTICLE; CELL CULTURE; CENTROMERE; CHROMATID; CHROMOSOMAL INSTABILITY; CHROMOSOME 22; CHROMOSOME ANALYSIS; CHROMOSOME NUMBER; DIPLOIDY; GENE INACTIVATION; GENOTYPE; HUMAN; HUMAN TISSUE; KARYOTYPE; MENINGIOMA; METAPHASE; MITOSIS SPINDLE; MONOSOMY; MULTINUCLEAR CELL; NF2 GENE; PRESCHOOL CHILD; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 16844368220     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/64.4.312     Document Type: Article

References (39)

1. Evans DG, Trueman L, Wallace A, et al. Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): Evidence for more severe disease associated with truncating mutations. J Med Genet 1998;35:450-55
2. Trofatter JA, MacCollin MM, Rutter JL, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993;72:791-800
3. Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene gencoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 1993;363:515-21
4. Ruttledge MH, Sarrazin J, Rangaratnam S, et al. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 1994;6:180-84
5. Papi L, De Vitis LR, Vitelli F, et al. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Hum Genet 1995;95:347-51
6. Carlson KM, Bruder C, Nordenskjold M, et al. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization. Genes Chromosomes Cancer 1997;20:419-24
7. Wellenreuther R, Kraus JA, Lenartz D, et al. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 1995;146:827-32
8. Evans JJ, Jeun SS, Lee JH, et al. Molecular alterations in the neurofibromatosis type 2 gene and its protein rarely occurring in meningothelial meningiomas. J Neurosurg 2001;94:111-17
9. Kros J, de Greve K, van Tilborg A, et al. NF2 status of meningiomas is associated with tumor localization and histology. J Pathol 2001;194:367-72
10. Lekanne Deprez RH, Riegman PH, van Drunen E, et al. Cytogenetic, molecular genetic and pathologic analyses in 126 meningiomas. J Neuropathol Exp Neurol 1995;54:224-35
11. Sawyer JR, Husain M, Pravdenkova S, et al. A role for telomeric and centromeric instability in the progression of chromosome aberrations in meningioma patients. Cancer 2000;88:440-53
12. Poulsgard L, Ronne M, Schroder HD. Cytogenetic studies of 19 meningiomas and their clinical significance. I. Anticancer Res 1989;9:109-12
13. Maltby EL, Ironside JW, Battersby RD. Cytogenetic studies in 50 meningiomas. Cancer Genet Cytogenet 1988;31:199-210
14. Meloni A, Morgan R, Bridge J, et al. Cytogenetic findings in typical and atypical meningioma. Cancer Genet Cytogenet 1991;51:35-39
15. Zang KD. Meningioma: A cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Cell Genet 2001;93:207-20
16. Cerda-Nicolas M, Lopez-Gines C, Perez-Bacete M, et al. Histopathologic and cytogenetic findings in benign, atypical and anaplastic human meningiomas: A study of 60 tumors. Clin Neuropathol 2000;19:259-67
17. Zang KD. Cytological and cytogenetical studies on human meningioma. Cancer Genet Cytogenet 1982;6:249-74
18. Weber RG, Bostrom J, Wolter M, et al. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: Toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 1997;94:14719-24
19. Simon M, Kokkino AJ, Warnick RE, et al. Role of genomic instability in meningioma progression. Genes Chromosomes Cancer 1996;16:265-69
20. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67
21. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993;9:138-41
22. Saunders WS, Shuster M, Huang X, et al. Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc Natl Acad Sci USA 2000;97:303-8
23. Kaplan KB, Burds AA, Swedlow JR, et al. A role for the Adenomatous Polyposis Coli protein in chromosome segregation. Nat Cell Biol 2001;3:429-32
24. Gisselsson D, Pettersson L, Hoglund M, et al. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc Natl Acad Sci USA 2000;97:5357-62
25. Gisselsson D, Bjork J, Hoglund M, et al. Abnormal nuclear shape in solid tumors reflects mitotic instability. Am J Pathol 2001;158:199-206
26. Erenpreisa J, Cragg MS. Mitotic death: A mechanism of survival? A review. Cancer Cell Int 2001;1:1
27. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215
28. van Tilborg AA, de Vries A, de Bont M, et al. Molecular evolution of multiple recurrent cancers of the bladder. Hum Mol Genet 2000;9: 2973-80
29. Mitelman F, editor. ISCN: Guidelines for cancer cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. Basel: S. Karger, 1995
30. Legoix P, Legrand MF, Ollagnon E, et al. Characterisation of 16 polymorphic markers in the NF2 gene: Application to hemizygosity detection. Hum Mutat 1999;13:290-93
31. Gisselsson D, Jonson T, Yu C, et al. Centrosomal abnormalities, multipolar mitoses, and chromosomal instability in head and neck tumors with dysfunctional telomeres. Br J Cancer 2002;87:202-7
32. Yoon DS, Wersto RP, Zhou W, et al. Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer. Am J Pathol 2002;161:391-97
33. Rajagopalan H, Nowak MA, Vogelstein B, et al. The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer 2003;3:695-701
34. Shah JV, Cleveland DW. Waiting for anaphase: Mad2 and the spindle assembly checkpoint. Cell 2000;103:997-1000
35. Schar P. Spontaneous DNA damage, genome instability, and cancer: When DNA replication escapes control. Cell 2001;104:329-32
36. Sumner AT. Induction of diplochromosomes in mammalian cells by inhibitors of topoisomerase II. Chromosoma 1998;107:486-90
37. Ghosh S, Paweletz N, Schroeter D. Failure of centromere separation leads to formation of diplochromosomes in next mitosis in okadaic acid treated HeLa cells. Cell Biol Int 1993;17:949-52
38. Ruttledge MH, Andermann AA, Phelan CM, et al. Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet 1996;59:331-42
39. Zwarthoff EC. Neurofibromatosis and associated tumor suppressor genes. Pathol Res Pract 1996;192:647-57